However, many LGMD-causing mutations affect proteins localized to the plasma membrane such as dystroglycan, sarcoglycans, caveolin-3 (CAV3), and dysferlin (DYSF) or the nuclear envelope (lamin A/C (LMNA)) [64]. The gene discussed is CAV3; the disease is limb-girdle muscular dystrophy.